12.4 Central Fill, Centralized Processing & Automation

12.4 Central Fill, Centralized Processing & Automation

Quick Answer: Rule 6800.4075 permits centralized prescription filling or processing when pharmacies have the same owner or a written contract, share a common electronic file (or equivalent access), hold proper §151.19 / 6800.0300 licensure, and provide the Board a policy and procedures manual at least 30 days before services begin. The pharmacy that dispenses/delivers/mails/ships the completed order to the patient owns certification and counseling. Rule 6800.2600 forbids automated counting/distribution of legend drugs except under Board-notified systems with policies, training, and accountability—notify the Board at least 60 days before initial use.

NABP Area 4 expressly tests central fill and facility systems. Minnesota’s rules are detailed enough that commercial flashcards often under-teach them—learn the contract + electronic access + Board notice + who counsels chain for central services, and the notification + certification + audit chain for automation.

Centralized Prescription Processing and Filling (Rule 6800.4075)

Licensure first

Subpart 1:

• A central service pharmacy in another state that provides centralized services to a Minnesota pharmacy must be licensed as a nonresident pharmacy under §151.19 (nonresident structure).
• A central service pharmacy in Minnesota that provides those services to a pharmacy in any state must be licensed as a pharmacy under §151.19, subd. 1.

Central fill is not a loophole around facility licensure.

Conditions before outsourcing (Subp. 2.A)

A pharmacy may perform or outsource centralized filling/processing only if all apply:

1. Same owner or a written contract outlining services, responsibilities, and accountabilities in compliance with federal and state law
2. A common electronic file or technology giving access to information necessary to fill or refill the order
3. The central service pharmacy is licensed according to part 6800.0300
4. The parties provide the Board a copy of the policy and procedures manual at least 30 days before centralized processing services begin

Manual contents (Subp. 2.B)

The P&P manual (available to the Board on request) must include at least:

Certification, counseling, and patient notice

Subpart 3:

• A pharmacist or pharmacist-intern at the pharmacy that dispenses, delivers, mails, or ships the completed prescription to the patient is responsible for certifying the completed order (except as provided in §151.215).
• The same patient-facing pharmacy’s pharmacist/intern is responsible for counseling under Rule 6800.0910.

Subpart 4: A pharmacy using a central service pharmacy for dispensing functions, DUR, packaging, labeling, delivery of a completed order, or other services must notify its patients of that fact.

Exam method: identify (1) which site is licensed, (2) whether contract/common ownership exists, (3) whether Board got the manual ≥30 days prior, (4) which site faces the patient for certification/counseling, and (5) whether patients were notified.

Automated Counting and Distribution (Rule 6800.2600)

Default prohibition + notification gate

Subpart 1 states it is unlawful to count, distribute, dispense, or vend any legend drug through an automated counting device, automated drug distribution system, or vending machine except as provided in the rule.

Before initial use, the pharmacy must give the Board written notification at least 60 days in advance, including:

• Location of the device/system
• Name and address of the pharmacy responsible for control
• Written policies and procedures governing operation (including staff training and subpart 2/3 requirements)
• Name of the PIC

The pharmacy may proceed unless the Board provides written notice within 60 days of receiving the documents that the device/system may not be used (with steps required for approval).

Training

Training must be conducted by qualified individuals on a continuing basis, with documentation of names and unique identifiers of staff trained, trainer identity/unique identifier, and training date—available to the Board on request.

Automated counting devices (Subp. 2)

Counting devices (cell/cassette systems that count solid doses) must follow prepackaging-style fill and labeling controls from Rule 6800.3200 as specified, fill only one cell/cassette at a time, calibrate/verify accuracy on a regular basis, prevent cross-contamination, maintain continuous quality assurance, and specify verification methods when the manufacturer’s stock container is unavailable.

Automated drug distribution systems (Subp. 3)

Hospital/LTC-style cabinets and similar systems face additional controls:

1. Pharmacist review, interpretation, and approval of all prescription drug orders before any drug is distributed for administration—except when a formal written P&T (or equivalent) decision authorizes limited access for specified patient-care circumstances, drugs, and staff.
2. Individual-specific access codes or biometric access; policies for time-outs, log-offs, and lock-outs.
3. Electronic records of who accessed, reason, date/time, drug details and quantities removed/returned/wasted, patient name, and other PIC-required data—reviewed for discrepancies with PIC responsibility for quality, accuracy, timeliness, and corrective action.
4. P&T list of drugs/categories prohibited from automated distribution, reviewed at least annually; high-alert drugs need committee determination they need not be prohibited.
5. Open matrix drawers limited for CS (generally only if the entire drawer is a single CS product) with narrow noncontrolled exceptions.
6. High-alert removals checked by a second licensed health professional unless listed exceptions apply (prior pharmacist review, practitioner-controlled procedure, or emergency practitioner determination).
7. Pharmacist certification of packaging, labeling, and stocking—documented and retained at least two years (fail-safe barcoding may support certification as provided).
8. Devices secured or kept in a locked medication room when not in actual use.
9. Unused drugs returned to pharmacy or secure return bin; restocking only by designated certified pharmacy personnel.
10. Monthly assessments of location, dating, approved stock, inventory levels, and security (each element at least monthly).
11. At least monthly CS audit for accuracy of distribution and recordkeeping.
12. Patient confidentiality protections and wastage/return policies.
13. Continuous quality assurance / failure-mode analysis for system and process failures, high-alert drugs, errors, and CS discrepancies.

Statute note: Minn. Stat. §151.58 also addresses automated drug distribution for patients of health care facilities—use the statute/rule pair when stems mention facility ADCs.

Accountability Themes That Connect Central Fill and Automation

Common MPJE Traps

• Assuming central fill eliminates counseling duties at the patient-facing pharmacy
• Starting central processing without Board manual filing
• Using an ADC without 60-day Board notification package
• Letting nurses pull non-override medications before pharmacist review without a valid P&T emergency protocol
• Skipping monthly controlled-substance ADC audits
• Treating machine counting as a substitute for certification of accuracy

Study Checklist

1. List 6800.4075 conditions: ownership/contract, electronic access, licensure, 30-day Board manual, tracking, multi-pharmacy labeling, PHI security, CQI.
2. Name who certifies and counsels the completed order to the patient.
3. State patient notification duty for central service use.
4. Recite 6800.2600 default prohibition + 60-day Board notification + training with unique identifiers.
5. Explain pharmacist pre-distribution review, individual access, monthly CS audit, and 2-year certification records for distribution systems.

Central fill and automation scale operations—but Minnesota law still demands a licensed pharmacy, a named PIC, and a human accountability chain the Board can audit.